Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Overview of attention for article published in New England Journal of Medicine, March 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 26 news outlets
blogs: 8 blogs
policy: 3 policy sources
twitter: 63 X users
patent: 10 patents
facebook: 10 Facebook pages

wikipedia: 1 Wikipedia page
googleplus: 1 Google+ user
reddit: 5 Redditors
f1000: 1 research highlight platform
guideline: 17 clinical guideline sources

Readers on

mendeley: 973 Mendeley

So far, Altmetric has seen 5 Reddit threads by 5 users.

>Repatha Repatha efficacy is reported as 61%, which is...

User smart-monkey-org, in the PeterAttia subreddit, 05 Dec 2023

>Repatha Repatha efficacy is reported as 61%, which is quite strong https://www.nejm.org/doi/full/10.1056/nejmoa1500858

> You continue to ignore the actual primary endpoints of...

User [deleted], in the nutrition subreddit, 23 Apr 2018

> You continue to ignore the actual primary endpoints of these…

Posting this because it has been making rounds around the...

User HFpEF, in the /r/medicine: a subreddit for medical professionals subreddit, 04 Apr 2017

Posting this because it has been making rounds around the hospital and haven't seen it here. We might be looking back at this…

Phase III trials show PCSK9 inhibitors significantly reduce LDL when added to statin therapy

User fair_at_best, in the Pharmacy subreddit, 17 Mar 2015

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity, including 1 additional Reddit threads.